Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ReposiTrak (TRAK) EBT (2016 - 2025)

Historic EBT for ReposiTrak (TRAK) over the last 16 years, with Q3 2025 value amounting to $2.3 million.

  • ReposiTrak's EBT rose 2503.22% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.1 million, marking a year-over-year increase of 2158.41%. This contributed to the annual value of $7.7 million for FY2025, which is 2086.28% up from last year.
  • As of Q3 2025, ReposiTrak's EBT stood at $2.3 million, which was up 2503.22% from $2.0 million recorded in Q2 2025.
  • Over the past 5 years, ReposiTrak's EBT peaked at $2.3 million during Q3 2025, and registered a low of $783152.0 during Q1 2021.
  • In the last 5 years, ReposiTrak's EBT had a median value of $1.5 million in 2023 and averaged $1.5 million.
  • Over the last 5 years, ReposiTrak's EBT had its largest YoY gain of 18682.16% in 2021, and its largest YoY loss of 4329.42% in 2021.
  • Over the past 5 years, ReposiTrak's EBT (Quarter) stood at $927343.0 in 2021, then surged by 42.92% to $1.3 million in 2022, then increased by 18.1% to $1.6 million in 2023, then rose by 8.82% to $1.7 million in 2024, then skyrocketed by 33.25% to $2.3 million in 2025.
  • Its last three reported values are $2.3 million in Q3 2025, $2.0 million for Q2 2025, and $2.1 million during Q1 2025.